Pharmacogenetic testing, which is used to classify how patients with major depressive disorder (MDD) metabolize medications, reduces adverse drug-gene interactions, new research shows. In a randomized ...
Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...
This study used Mendelian randomisation to test potential causal relationships between depression and 137 traits. Depression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback